Skip to content
Prime Therapeutics, Main logo
  • Health plans
  • Employers
  • Consultants
  • Careers
  • Resources
    • Pharmacist + Provider
    • Client + Health Plan
Member Sign In
  • About
    • Overview
    • Our History
    • Culture
    • Our Leaders
  • Who We Serve
    • Health plans
    • Employers
    • Consultants
  • News
  • Products
  • Resources
    • Pharmacy + provider
    • Client and health plan
  • Careers
    • Overview
    • Benefits
    • Open Positions
  • Contact
Member Sign In
Home/Client Communications/October 2023 decisions expected from the FDA

October 2023 decisions expected from the FDA

September 11, 2023

Your monthly synopsis of new drugs expected to hit the market.

Prime Therapeutics Logo

Navigate

  • About
  • Products
  • News
  • Resources
  • Careers
  • Contact

Other Websites

  • Magellan Rx
  • myprime.com

Legal

  • Privacy Policy
  • Terms of Use
  • Subrogation
Prime Therapeutics Logo

Stay Connected

NCQA Certified Health Information Product
urac Accreditted Pharmacy Benefit Management Award Image with Logo
HITrust CSF Certfied
AICPA SOC for Service Organizations certification

© 2023 Prime Therapeutics LLC | Magellan Rx Management, LLC, a Prime Therapeutics LLC company